Penn spinout led by veteran pharma execs emerges from stealth mode, raises $50M to advance gene-editing technology

The company's technology is the culmination of more than 30 years of gene therapy and editing experience developed in the laboratory of Dr. Jim Wilson.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news